Legalise medicinal cannabis, MPs urgeBMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i4986 (Published 19 September 2016) Cite this as: BMJ 2016;354:i4986
- Anne Gulland
A cross party group of MPs and peers has urged the government to legalise cannabis for medicinal purposes.
In a new report the All Party Parliamentary Group on Drug Policy Reform has called for the reclassification of cannabis to enable patients to get hold of the drug “without suffering the added stress of breaking the law.”1
Cannabis is currently listed under schedule one, the schedule for dangerous drugs with no medicinal value. However, the government has approved the cannabis derivative nabiximols (Sativex) for the treatment of spasticity and the synthetic cannabinoid nabilone to control nausea …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial